To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Paul Capital, TVM, Signet invest €26m in Euro pharma company
Paris-based specialty pharmaceutical company SpePharm will use €10m to fund the acquisition of a Proctor & Gamble product.
